Subsidiary company Sainte Company of Shandong Lukang Pharmaceutical (600789.SH) has become the holder of the marketing approval for Dapoxetine hydrochloride tablets (30mg, 60mg).

Shandong Lukang Pharmaceutical (600789.SH) announced that its subsidiary, Shandong Lukang Pharmaceutical Group Sate Co., Ltd. (Sate Company), has received the approval from the National Medical Products Administration to be the holder of the market approval for Hydrochloride Dapoxetine Tablets (Notification Numbers: 2024B04297, 2024B04298). The subsidiary Sate Company has become the holder of the market approval for Hydrochloride Dapoxetine Tablets (30mg, 60mg), which will further enrich the company's line of products for male health, and help with the company's sustainable development.